Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156844778> ?p ?o ?g. }
- W2156844778 endingPage "2702" @default.
- W2156844778 startingPage "2694" @default.
- W2156844778 abstract "The anabolic actions of GH are mediated by the production of insulin-like growth factor I (IGF-I) from the liver and by local production of IGF-I in extrahepatic tissues. Insulin facilitates the hepatic production of IGF-I by up-regulating GH receptors (GHRs) in the liver and augmenting the IGF-I response to GH. Although GHRs have also been identified in extrahepatic tissues that produce IGF-I, the possibility that IGF-I and insulin might partake in GHR regulation, thereby modulating the effects of GH locally has not received detailed study. The aim of this study was to investigate whether IGF-I and insulin are involved in the local regulation of GHRs, using osteoblasts as a model of GH-responsive extrahepatic tissues. We have used UMR106.06, a well differentiated rat osteoblast-like cell line that expresses GHRs and exhibits a mitogenic response to GH. IGF-I and insulin (0-10 nM) increased cell number and reduced [125I]GH binding in a concentration-dependent manner, with ED50 values of 0.8 and 0.3 nM, respectively. Although IGF-I increased cell number maximally by 36.9 +/- 1.2% (mean +/- SE) above the control value and insulin by 104.8 +/- 5.7% (P < 0.001), they decreased GH binding to 47.0 +/- 9.3% (P < 0.01) and 29.8 +/- 8.7% of the control value (P < 0.001), respectively. Scatchard analysis revealed that the down-regulation of GH binding was attributed to reduced receptor numbers and not binding affinity. The effects of IGF-I and insulin at submaximal concentrations were additive, although the combined effects did not exceed the maximal effect of either growth factor alone. Addition of an anti-IGF-I receptor antibody (alpha IR3) reversed the inhibition of GH binding induced by IGF-I, but not that caused by insulin; similarly, an antiinsulin receptor antibody (29B4) attenuated the inhibitory effect of insulin only. Addition of alpha IR3 alone or an ant-IGF-I antibody (Sm1.2) decreased cell number and increased GH binding in a concentration-dependent mode. GH at 1.5 nM significant increased cell number by 19.3 +/- 2.4% above the control level (P < 0.01), an increase that was reversed by alpha IR3. GH increased GH binding by 32.4 +/- 7.2% (P < 0.05) in cells treated with alpha IR3 to remove the secondary effect of IGF-I. In summary, IGF-I and insulin acted via specific receptors to stimulate cell proliferation and down-regulate GHRs in osteoblasts. GH stimulated cell proliferation, an action mediated by local production of IGF-I, and GH enhanced its own binding. The collective data suggest the presence of a peripheral negative feedback loop that allows IGF-I to limit locally the response of extrahepatic tissues to circulating GH." @default.
- W2156844778 created "2016-06-24" @default.
- W2156844778 creator A5003412422 @default.
- W2156844778 creator A5016053268 @default.
- W2156844778 creator A5028028705 @default.
- W2156844778 creator A5045249051 @default.
- W2156844778 creator A5049748839 @default.
- W2156844778 creator A5050397488 @default.
- W2156844778 date "1996-07-01" @default.
- W2156844778 modified "2023-10-15" @default.
- W2156844778 title "Insulin-like growth factor I and insulin down-regulate growth hormone (GH) receptors in rat osteoblasts: evidence for a peripheral feedback loop regulating GH action." @default.
- W2156844778 cites W1510419162 @default.
- W2156844778 cites W1576735603 @default.
- W2156844778 cites W1972083618 @default.
- W2156844778 cites W1987495895 @default.
- W2156844778 cites W1995555012 @default.
- W2156844778 cites W1998761507 @default.
- W2156844778 cites W2004377799 @default.
- W2156844778 cites W2008232947 @default.
- W2156844778 cites W2012316425 @default.
- W2156844778 cites W2013659927 @default.
- W2156844778 cites W2018717300 @default.
- W2156844778 cites W2019349161 @default.
- W2156844778 cites W2026870334 @default.
- W2156844778 cites W2029380858 @default.
- W2156844778 cites W2031938665 @default.
- W2156844778 cites W2037220072 @default.
- W2156844778 cites W2039248225 @default.
- W2156844778 cites W2050895869 @default.
- W2156844778 cites W2065298029 @default.
- W2156844778 cites W2072573450 @default.
- W2156844778 cites W2080186835 @default.
- W2156844778 cites W2081075932 @default.
- W2156844778 cites W2083137296 @default.
- W2156844778 cites W2083744069 @default.
- W2156844778 cites W2084677159 @default.
- W2156844778 cites W2093029203 @default.
- W2156844778 cites W2102123572 @default.
- W2156844778 cites W2120497689 @default.
- W2156844778 cites W2125964591 @default.
- W2156844778 cites W2128263192 @default.
- W2156844778 cites W2132462173 @default.
- W2156844778 cites W2144294273 @default.
- W2156844778 cites W2145996190 @default.
- W2156844778 cites W2169846268 @default.
- W2156844778 cites W2172032243 @default.
- W2156844778 cites W2471277785 @default.
- W2156844778 cites W3765645 @default.
- W2156844778 doi "https://doi.org/10.1210/endo.137.7.8770888" @default.
- W2156844778 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8770888" @default.
- W2156844778 hasPublicationYear "1996" @default.
- W2156844778 type Work @default.
- W2156844778 sameAs 2156844778 @default.
- W2156844778 citedByCount "39" @default.
- W2156844778 countsByYear W21568447782013 @default.
- W2156844778 countsByYear W21568447782014 @default.
- W2156844778 countsByYear W21568447782018 @default.
- W2156844778 countsByYear W21568447782019 @default.
- W2156844778 countsByYear W21568447782020 @default.
- W2156844778 crossrefType "journal-article" @default.
- W2156844778 hasAuthorship W2156844778A5003412422 @default.
- W2156844778 hasAuthorship W2156844778A5016053268 @default.
- W2156844778 hasAuthorship W2156844778A5028028705 @default.
- W2156844778 hasAuthorship W2156844778A5045249051 @default.
- W2156844778 hasAuthorship W2156844778A5049748839 @default.
- W2156844778 hasAuthorship W2156844778A5050397488 @default.
- W2156844778 hasBestOaLocation W21568447781 @default.
- W2156844778 hasConcept C1008401 @default.
- W2156844778 hasConcept C112446052 @default.
- W2156844778 hasConcept C113675107 @default.
- W2156844778 hasConcept C126322002 @default.
- W2156844778 hasConcept C134018914 @default.
- W2156844778 hasConcept C170493617 @default.
- W2156844778 hasConcept C2775960820 @default.
- W2156844778 hasConcept C2777391703 @default.
- W2156844778 hasConcept C2779306644 @default.
- W2156844778 hasConcept C2780689927 @default.
- W2156844778 hasConcept C2984496839 @default.
- W2156844778 hasConcept C71315377 @default.
- W2156844778 hasConcept C71924100 @default.
- W2156844778 hasConcept C86803240 @default.
- W2156844778 hasConceptScore W2156844778C1008401 @default.
- W2156844778 hasConceptScore W2156844778C112446052 @default.
- W2156844778 hasConceptScore W2156844778C113675107 @default.
- W2156844778 hasConceptScore W2156844778C126322002 @default.
- W2156844778 hasConceptScore W2156844778C134018914 @default.
- W2156844778 hasConceptScore W2156844778C170493617 @default.
- W2156844778 hasConceptScore W2156844778C2775960820 @default.
- W2156844778 hasConceptScore W2156844778C2777391703 @default.
- W2156844778 hasConceptScore W2156844778C2779306644 @default.
- W2156844778 hasConceptScore W2156844778C2780689927 @default.
- W2156844778 hasConceptScore W2156844778C2984496839 @default.
- W2156844778 hasConceptScore W2156844778C71315377 @default.
- W2156844778 hasConceptScore W2156844778C71924100 @default.
- W2156844778 hasConceptScore W2156844778C86803240 @default.
- W2156844778 hasIssue "7" @default.
- W2156844778 hasLocation W21568447781 @default.
- W2156844778 hasLocation W21568447782 @default.